Cargando…

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives

The definition of a biomarker provided by the World Health Organization is any substance, structure, or process that can be measured in the body, or its products and influence, or predict the incidence or outcome of disease. Currently, the lack of prognosis and progression markers for chronic Chagas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinazo, Maria-Jesus, Thomas, Maria-Carmen, Bustamante, Juan, de Almeida, Igor Correia, Lopez, Manuel-Carlos, Gascon, Joaquim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Oswaldo Cruz, Ministério da Saúde 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489480/ https://www.ncbi.nlm.nih.gov/pubmed/25946151 http://dx.doi.org/10.1590/0074-02760140435

Ejemplares similares

Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response
por: Pinazo, Maria-Jesus, et al.
Publicado: (2016)

Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease
por: Cortes-Serra, Nuria, et al.
Publicado: (2020)

State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
por: Gabaldón-Figueira, Juan Carlos, et al.
Publicado: (2023)

Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease
por: Cortes-Serra, Nuria, et al.
Publicado: (2022)

In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2019)

Corrigendum: In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2020)

Immunosuppression and Chagas Disease: A Management Challenge
por: Pinazo, María-Jesús, et al.
Publicado: (2013)

Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia
por: Pinazo, Maria-Jesus, et al.
Publicado: (2021)

Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease
por: Martínez-Peinado, Nieves, et al.
Publicado: (2021)

Chagas Disease among the Latin American Adult Population Attending in a Primary Care Center in Barcelona, Spain
por: Roca, Carme, et al.
Publicado: (2011)

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform
por: Pinazo, Maria-Jesus, et al.
Publicado: (2017)

New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia
por: Alonso-Vega, Cristina, et al.
Publicado: (2021)

A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease
por: Montoya, Alba L., et al.
Publicado: (2022)

Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network
por: Pinazo, Maria-Jesus, et al.
Publicado: (2022)

Characterization of digestive disorders of patients with chronic Chagas disease in Cochabamba, Bolivia
por: Pinto, Jimy-Jose, et al.
Publicado: (2019)

Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis
por: Cortes-Serra, Nuria, et al.
Publicado: (2020)

Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis
por: Egüez, Karina E., et al.
Publicado: (2017)

High prevalence of S. Stercoralis infection among patients with Chagas disease: A retrospective case-control study
por: Puerta-Alcalde, Pedro, et al.
Publicado: (2018)

Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives
por: Anastasiu, Costin Vlad, et al.
Publicado: (2020)

Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
por: Garcia-Alvarez, Ana, et al.
Publicado: (2010)

Use of rapid diagnostic tests (RDTs) for conclusive diagnosis of chronic Chagas disease – field implementation in the Bolivian Chaco region
por: Lozano, Daniel, et al.
Publicado: (2019)

Therapeutic siRNA: State-of-the-Art and Future Perspectives
por: Friedrich, Maik, et al.
Publicado: (2022)

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
por: Gómez-Aguado, Itziar, et al.
Publicado: (2020)

Neuroenhancement: State of the Art and Future Perspectives
por: Marazziti, Donatella, et al.
Publicado: (2021)

Perspectives for a new drug candidate for Chagas disease therapy
por: Soeiro, Maria de Nazaré Correia
Publicado: (2022)

Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus
por: Alonso-Padilla, Julio, et al.
Publicado: (2020)

Use of Early Biomarkers in Neonatal Brain Damage and Sepsis: State of the Art and Future Perspectives
por: Bersani, Iliana, et al.
Publicado: (2015)

The health-related quality of life in patients with Chagas disease: the state of the art
por: de Almeida, Igor Lucas Geraldo Izalino, et al.
Publicado: (2022)

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
por: Cocco, Stefania, et al.
Publicado: (2020)

Glioblastoma Treatment: State-of-the-Art and Future Perspectives
por: Rodríguez-Camacho, Alejandro, et al.
Publicado: (2022)

Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives
por: Merola, Elettra, et al.
Publicado: (2022)

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
por: Torrico, Faustino, et al.
Publicado: (2022)

Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers
por: Fernández-Villegas, Ana, et al.
Publicado: (2011)

Glioblastoma: State of the Art and Future Perspectives
por: Tabatabai, Ghazaleh, et al.
Publicado: (2019)

The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives
por: Fiore, Michele, et al.
Publicado: (2021)

Focused Ultrasound in Neuroscience. State of the Art and Future Perspectives
por: Giammalva, Giuseppe Roberto, et al.
Publicado: (2021)

Automatic breast ultrasound: state of the art and future perspectives
por: Nicosia, Luca, et al.
Publicado: (2020)

Pulmonary Infiltrates and Eosinophilia in a 25-Year-Old Traveler
por: Muñoz, Jose, et al.
Publicado: (2013)

CAR-T State of the Art and Future Challenges, A Regulatory Perspective
por: Giorgioni, Lorenzo, et al.
Publicado: (2023)

Subliminal Priming—State of the Art and Future Perspectives
por: Elgendi, Mohamed, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bu7rt0hfsn396j075damoccnk7